KYG2110P1000
KYG2110P1000
SHINEWAY PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.135.419.000 | 3.778.043.000 | 17.0% |
| Cost of Revenue | 869.212.000 | 946.294.000 | 8.1% |
| Gross Profit | 2.266.207.000 | 2.831.749.000 | 20.0% |
| 1.548.405.000 | 1.989.147.000 | 22.2% | |
| Operating Income | 717.802.000 | 842.602.000 | 14.8% |
| Pretax Income | 1.269.266.000 | 1.145.721.000 | 10.8% |
| Net Income Common Stockholders | 949.948.000 | 840.052.000 | 13.1% |
| -- | -- | -- | |
| -- | -- | -- |